Gaia Sciences Innovation
GSI is a £200m impact fund leveraging exclusive access to the world’s largest network of leading bioscience institutes to invest in and scale best-in-class businesses that mitigate climate change and biodiversity loss.
Gaia Sciences Innovation Fund
The fund invests in both spin-outs from our exclusive network of partner institutes and best-in-class third party companies.
GSI brings together leading partner institutions home to more than 4,000 scientists, including RBG Kew, ZSL, University of York, UK Centre for Ecology & Hydrology, and via the Anglia Innovation Partnership, the Earlham Institute, John Innes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Quadram Institute, The Sainsbury Laboratory and the University of East Anglia.
The fund focuses on three areas:
- Greening real assets: Investing in businesses that make commercial agriculture and forestry more sustainable and enhance or restore land and water-based ecosystems.
- Green Fintech: Investing in world-class, resilient solutions to measure, monitor and verify natural capital assets and supply chains to provide the depth and integrity of data to scale efficient markets and exchanges of these assets.
- Human Systems (Food and Waste) and Human Wellness: Investing in greening and improving the resilience of human processes from human food systems and waste streams to human wellness.
We invest in companies that make commercial agriculture and forestry more sustainable and enhance or restore land and water-based ecosystems. Examples of sub-sectors we invest in are science based regenerative agricultural applications, natural pest control, green fertiliser and products that enhance soil health, afforestation and habitat restoration advisory, enhanced carbon dioxide sequestration, and improved watershed management.
We invest in companies that provide technology and expertise that can underpin and unlock green financial markets. This includes technologies to measure, monitor, verify and calibrate ecosystem services and climate impacts on natural capital supply chains, including technologies for environmental DNA collection and sequencing, sensors for tracking water and soil health, computational genetics, and AI for assessing climate and nature-related risks.
We invest in solutions that improve the resilience of human supply chains (from food to medicine) and ease pressures on ecosystems or adapt to changing conditions, for example through climate-resilient food crops, developing alternatives that displace drivers of deforestation such as meat, dairy and palm oil, and using plants for drug discovery or producing bioactive compounds.
GSI Portfolio Companies
Kew REACH is Gaia Sciences Innovation’s first investment. Kew REACH offers a holistic approach to nature restoration, enhancement, adaptation and creation. Based on Kew’s deep experience in researching, managing, and enhancing landscapes, it is powered by Kew’s cutting-edge science, and knowhow (the ‘Kew Method’).
Kew REACH works with major corporates, landowners and commercial agricultural and forestry owners and operators to create positive environmental impact. We advise stakeholders and clients on how to either improve or create outstanding natural habitats in commercial agriculture, forestry, real estate, and natural landscapes with science-led, high-credibility solutions. Powered by Kew Science, it provides scientific knowhow, transparency, data, and accountability, ensuring scientific rigour and data is at the heart of any project it advises.
For more information please visit